SUMATRIPTAN, GR-43175
1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]- N-methyl-methanesulfonamide
3-[2-(Dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide
Formula | C14H21N3O2S |
---|---|
Mol. mass | 295.402 g/mol |
CAS number | 103628-46-2 |
---|
Avanir Pharmaceuticals has filed a new drug application (NDA) with the US Food and Drug Administration (FDA) for approval of its new breath-powered investigational drug-device combination product, ‘AVP-825’, for the acute treatment of migraines. click on title Avanir files new drug application for migraine drug
SUMATRIPTAN
SUMATRIPTAN SUCCINATE
View original post 2,722 more words